<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the expression of survivin <z:chebi fb="2" ids="33699">mRNA</z:chebi> in <z:e sem="disease" ids="C0848852,C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancy</z:e> cells and its correlation with HHT-induced cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:e sem="disease" ids="C0848852,C0376545" disease_type="Neoplastic Process" abbrv="">Hematological malignancy</z:e> cell lines MUTZ-1, K562, Jurkat, RPMI and HL60 were treated with HHT in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>Cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was observed by flow cytometry (FCM) and the expression of surviving and XIAP <z:chebi fb="2" ids="33699">mRNA</z:chebi> was evaluated with semi-quantitative RT-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>RESULT: The expression of survivin <z:chebi fb="2" ids="33699">mRNA</z:chebi> on cell lines was negatively correlated to HHT-induced cell apoptotic rate (r=-0.980, P=0.003) </plain></SENT>
<SENT sid="4" pm="."><plain>There were no significant differences in XIAP expression among these 5 cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Survivin could be used as a new marker for drug-sensitivity and a new target for treatment of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
</text></document>